experspadmin

Identifying Candidates for Neoadjuvant or Adjuvant Anti-HER2 Therapy
Oncology

Identifying Candidates for Neoadjuvant or Adjuvant Anti-HER2 Therapy

patient care perspectives
By Sara M. Tolaney, MD, MPH
Fibrotic and Sclerotic Manifestations of Chronic Graft-versus-Host Disease
Oncology

Fibrotic and Sclerotic Manifestations of Chronic Graft-versus-Host Disease

expert roundtables
By John Koreth, MBBS, DPhil; Robert S. Negrin, MD; Sergio A. Giralt, MD
Immunotherapy in Endometrial Cancer: Current Progress and Future Directions
Oncology

Immunotherapy in Endometrial Cancer: Current Progress and Future Directions

expert roundtables
By Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS; David Scott Miller, MD, FACOG, FACS; Pamela T. Soliman, MD, MPH
Maximizing Survival Outcomes and Quality of Life in Chronic Lymphocytic Leukemia
Oncology

Maximizing Survival Outcomes and Quality of Life in Chronic Lymphocytic Leukemia

expert roundtables
By Jennifer R. Brown, MD, PhD; John C. Byrd, MD; Susan O’Brien, MD
Risk of Macular Atrophy After Long-term Intravitreal Anti-VEGF Therapy
Ophthalmology

Risk of Macular Atrophy After Long-term Intravitreal Anti-VEGF Therapy

patient care perspectives
By SriniVas R. Sadda, MD, FARVO
Load More